» Articles » PMID: 21272654

Automated Hippocampal Shape Analysis Predicts the Onset of Dementia in Mild Cognitive Impairment

Abstract

The hippocampus is involved at the onset of the neuropathological pathways leading to Alzheimer's disease (AD). Individuals with mild cognitive impairment (MCI) are at increased risk of AD. Hippocampal volume has been shown to predict which MCI subjects will convert to AD. Our aim in the present study was to produce a fully automated prognostic procedure, scalable to high throughput clinical and research applications, for the prediction of MCI conversion to AD using 3D hippocampal morphology. We used an automated analysis for the extraction and mapping of the hippocampus from structural magnetic resonance scans to extract 3D hippocampal shape morphology, and we then applied machine learning classification to predict conversion from MCI to AD. We investigated the accuracy of prediction in 103 MCI subjects (mean age 74.1 years) from the longitudinal AddNeuroMed study. Our model correctly predicted MCI conversion to dementia within a year at an accuracy of 80% (sensitivity 77%, specificity 80%), a performance which is competitive with previous predictive models dependent on manual measurements. Categorization of MCI subjects based on hippocampal morphology revealed more rapid cognitive deterioration in MMSE scores (p<0.01) and CERAD verbal memory (p<0.01) in those subjects who were predicted to develop dementia relative to those predicted to remain stable. The pattern of atrophy associated with increased risk of conversion demonstrated initial degeneration in the anterior part of the cornus ammonis 1 (CA1) hippocampal subregion. We conclude that automated shape analysis generates sensitive measurements of early neurodegeneration which predates the onset of dementia and thus provides a prognostic biomarker for conversion of MCI to AD.

Citing Articles

MRI-based mild cognitive impairment and Alzheimer's disease classification using an algorithm of combination of variational autoencoder and other machine learning classifiers.

Bit S, Dey P, Maji A, Khan T J Alzheimers Dis Rep. 2025; 8(1):1434-1452.

PMID: 40034356 PMC: 11863754. DOI: 10.1177/25424823241290694.


Alzheimer's disease biomarkers and their current use in clinical research and practice.

Hunter T, Santos L, Tovar-Moll F, De Felice F Mol Psychiatry. 2024; 30(1):272-284.

PMID: 39232196 DOI: 10.1038/s41380-024-02709-z.


Resistance exercise effects on hippocampus subfield volumes and biomarkers of neuroplasticity and neuroinflammation in older adults with low and high risk of mild cognitive impairment: a randomized controlled trial.

Vints W, Seikinaite J, Gokce E, Kusleikiene S, Sarkinaite M, Valatkeviciene K Geroscience. 2024; 46(4):3971-3991.

PMID: 38478179 PMC: 11226571. DOI: 10.1007/s11357-024-01110-6.


Atrophy of hippocampal subfields relates to memory decline during the pathological progression of Alzheimer's disease.

Xiao Y, Hu Y, Huang K Front Aging Neurosci. 2023; 15:1287122.

PMID: 38149170 PMC: 10749921. DOI: 10.3389/fnagi.2023.1287122.


Relationship between hippocampal subfield volumes and cognitive decline in healthy subjects.

Doran S, Carey D, Knight S, Meaney J, Kenny R, De Looze C Front Aging Neurosci. 2023; 15:1284619.

PMID: 38131011 PMC: 10733466. DOI: 10.3389/fnagi.2023.1284619.


References
1.
Dinov I, Van Horn J, Lozev K, Magsipoc R, Petrosyan P, Liu Z . Efficient, Distributed and Interactive Neuroimaging Data Analysis Using the LONI Pipeline. Front Neuroinform. 2009; 3:22. PMC: 2718780. DOI: 10.3389/neuro.11.022.2009. View

2.
Costafreda S, Chu C, Ashburner J, Fu C . Prognostic and diagnostic potential of the structural neuroanatomy of depression. PLoS One. 2009; 4(7):e6353. PMC: 2712086. DOI: 10.1371/journal.pone.0006353. View

3.
Apostolova L, Dutton R, Dinov I, Hayashi K, Toga A, Cummings J . Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol. 2006; 63(5):693-9. DOI: 10.1001/archneur.63.5.693. View

4.
Braak H, Braak E . Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991; 82(4):239-59. DOI: 10.1007/BF00308809. View

5.
Hughes C, Berg L, Danziger W, COBEN L, Martin R . A new clinical scale for the staging of dementia. Br J Psychiatry. 1982; 140:566-72. DOI: 10.1192/bjp.140.6.566. View